RITUXAN (Rituximab) Non-Hodgkin's Lymphoma

LinksLinks

By selecting any of the links below, you will be going to a site that is not controlled by or affiliated with Genentech, Inc. or Biogen Idec, Inc.

Genentech, Inc. and Biogen Idec, Inc. are neither affiliated with nor endorse any of the following organizations. The information provided by Genentech, Biogen Idec, or these organizations is meant for informational purposes only and is not meant to replace your physician's medical advice. Many of these organizations can refer you to a local chapter for more information.

Associations and Societies

American Cancer Society
A nationwide health organization dedicated to preventing cancer, saving lives, and diminishing suffering from cancer through research, education, and service.

American Institute for Cancer Research (AICR)
The nation's third largest cancer charity and a pioneer in the area of diet and nutrition as they pertain to the prevention and treatment of cancer.

The Leukemia and Lymphoma Society
The nation's largest voluntary health organization committed to improving the quality of life of patients and their families, and funding research grants to find cures for leukemia, lymphoma, Hodgkin's disease, and myeloma.

Lymphoma Information Network
A non-profit Internet site designed to offer lymphoma information resources to patients and family members.

Lymphoma Research Foundation (LRF)
This leading resource for information on lymphoma continues to assist patients in learning more about the disease, thereby helping them make educated decisions about the management of their disease.

National Cancer Institute (NCI)
Sponsored by the US government, this organization leads the nation's fight against cancer by supporting cancer research and promoting treatment, prevention, and quality of care for patients and their families.

Cancer Sites

CancerCare®
The oldest and largest national non-profit agency devoted to offering professional services, emotional support, and information to cancer patients, families, and healthcare professionals.

National Cancer Institute®
A service of the National Cancer Institute designed to provide recent and accurate cancer information to patients, caregivers, healthcare professionals, and researchers.

CancerSource™
Founded through an alliance with a leading publisher of cancer textbooks, its commitment is to providing comprehensive and accurate cancer information to consumers and healthcare professionals.

Lymphoma Focus
Information that represents the most current body of knowledge on lymphoma, enabling patients to make informed treatment and quality of life decisions and also assisting physicians in learning about new lymphoma treatments and cutting-edge research.

OncoLink™
Founded by University of Pennsylvania cancer specialists with a mission to help cancer patients, families, healthcare professionals, and the general public obtain accurate, free cancer-related information.

The Cancer Information Network
A noncommercial site founded to provide cancer patients and caregivers with the latest high-quality cancer information.

 

Important Safety Information

INDICATIONS

RITUXAN® (rituximab) is indicated for the treatment of patients with:

  • Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL as a single agent
  • Previously untreated follicular, CD20-positive, B-cell NHL in combination with CVP chemotherapy
  • Non-progressing (including stable disease), low-grade, CD20-positive B-cell NHL, as a single agent, after first-line CVP chemotherapy
  • Previously untreated diffuse large B-cell, CD20-positive NHL in combination with CHOP or other anthracycline-based chemotherapy regimens

IMPORTANT SAFETY INFORMATION

RITUXAN can cause serious side effects, some of which can be life-threatening, including: Progressive Multifocal Leukoencephalopathy (PML), infusion reactions, Tumor Lysis Syndrome (TLS), and severe skin reactions. Other serious and life-threatening side effects with RITUXAN include: hepatitis B virus reactivation, heart problems, infections, and stomach and bowel problems. Common side effects during RITUXAN infusions include: fever, headache, chills and shakes, nausea, itching, hives, cough, sneezing, and throat irritation or tightness.

Tell your doctor about any side effects that bother you or that do not go away. These are not all of the possible side effects with RITUXAN. Ask your doctor for more information.

Please read the Medication Guide in HTML or PDF versions for more information.